"I would go a step further and say we should utilise our differences to the max as well as bringing in others - An example of this is the Research & Development (R&D) Board we set up under the Partnership which has representation from both…"
"Not surprisingly I believe that a partnership approach is key - and in that partnership there should be no seniors, no juniors - just the acceptance of, and respect for each partner's expertise. And this MUST be coupled with the ability…"
"As for the enabling conditions I agree with my colleague Priya and this is why we created the GSK-Save the Children Healthcare Innovation Award - one designed to support initiatives developed for countries with low health resources by those with…"
"Jolene I concur with many of your points and would add the following:
Breaking down the challenge to facilitate creating a manageable innovation pilot at the expense of understanding the social system the behaviour change must be embedded…"
"The key drivers from my perspective are
Recognising that most social challenges, like the SDGs, are multidimensional, and so innovative socials must focus on the beneficiaries holistic needs (eg the social determinants of health)
"As I see it, the public sector is well placed to articulate the needs and priorities of citizens, and create an environment for these to be met. The social sector is well placed to support those most in need, providing them with a voice as…"
"If we keep doing the same things then we will keep getting the same results. Improving on current practices will undoubtedly lead to incremental improvements but transformational change needed to acheive the SDGs can't happen without…"
Following completion of my academic studies (PhD Immunology) at the University of Melbourne, I started work in the pharmaceutical industry. I have held a range of senior several medical, research and commercial positions covering a range of geographies and portfolios, and have worked in Australia, the UK and Italy. In 2008, I transferred to Belgium where GSK’s Vaccines Business is headquartered where I was Vice President of the Adult Vaccine Portfolio, leading the team that delivered successful management of the GSK Vaccines H1N1 pandemic and fostered the development of new quadrivalent flu and shingles vaccines. In 2012, I joined the corporate Government Affairs Public Policy & Patient Advocacy team where she led the negotiation of the first industry agreement to be signed with the WHO under the Pandemic Influenza Preparedness Framework whilst undertaking an MSc in Health Policy at the London School of Economics. My current role is heading the GSK-Save the Children Partnership which has the ambitious goal of helping to save the lives of 1 million children and I am also leading the Investment in Academia Initiative supporting GSK’s Africa and Developing Country Region 2020 strategy, as well as being the Global Head of GSK’s Access Medicines Portfolio.
Topics on my radar:
Base of the Pyramid, Education, Health, Inclusive Business Models, Partnerships, Social Enterprise, Women and Business
Other Topics on my radar:
SDGs, Maternal & Child Health, Child advocacy
No comments yet!
You need to be a member of Business Fights Poverty to add comments!